S Rashtak1, J A Murray. 1. Celiac Disease Research Program, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Abstract
BACKGROUND: Coeliac disease is managed by life-long gluten withdrawal from the diet. However, strict adherence to a gluten-free diet is difficult and is not always effective. Novel therapeutic approaches are needed to supplement or even replace the dietary treatment. AIM: To review recent advances in new therapeutic options for coeliac disease. METHODS: A literature search was performed on MEDLINE, EMBASE, Web of Science, Scopus, DDW.org and ClinicalTrials.gov for English articles and abstracts. The search terms used included, but not limited to, 'Celiac disease', 'new', 'novel', 'Advances', 'alternatives' and 'Drug therapy'. The cited articles were selected based on the relevancy to the review objective. RESULTS: Several new therapeutic approaches for coeliac disease are currently under development by targeting its underlying pathogenesis. Alternative therapies range from reproduction of harmless wheat strains to immunomodulatory approaches. Some of these therapies such as enzymatic cleavage of gluten and permeability inhibitors have shown promise in clinical studies. CONCLUSIONS: Gluten-free diet is still the only practical treatment for patients with coeliac disease. Novel strategies provide promise of alternative adjunctive approaches to diet restriction alone for patients with this disorder.
BACKGROUND:Coeliac disease is managed by life-long gluten withdrawal from the diet. However, strict adherence to a gluten-free diet is difficult and is not always effective. Novel therapeutic approaches are needed to supplement or even replace the dietary treatment. AIM: To review recent advances in new therapeutic options for coeliac disease. METHODS: A literature search was performed on MEDLINE, EMBASE, Web of Science, Scopus, DDW.org and ClinicalTrials.gov for English articles and abstracts. The search terms used included, but not limited to, 'Celiac disease', 'new', 'novel', 'Advances', 'alternatives' and 'Drug therapy'. The cited articles were selected based on the relevancy to the review objective. RESULTS: Several new therapeutic approaches for coeliac disease are currently under development by targeting its underlying pathogenesis. Alternative therapies range from reproduction of harmless wheat strains to immunomodulatory approaches. Some of these therapies such as enzymatic cleavage of gluten and permeability inhibitors have shown promise in clinical studies. CONCLUSIONS: Gluten-free diet is still the only practical treatment for patients with coeliac disease. Novel strategies provide promise of alternative adjunctive approaches to diet restriction alone for patients with this disorder.
Authors: Bertrand Meresse; Zhangguo Chen; Cezary Ciszewski; Maria Tretiakova; Govind Bhagat; Thomas N Krausz; David H Raulet; Lewis L Lanier; Veronika Groh; Thomas Spies; Ellen C Ebert; Peter H Green; Bana Jabri Journal: Immunity Date: 2004-09 Impact factor: 31.745
Authors: C Berlin; E L Berg; M J Briskin; D P Andrew; P J Kilshaw; B Holzmann; I L Weissman; A Hamann; E C Butcher Journal: Cell Date: 1993-07-16 Impact factor: 41.582
Authors: C Catassi; I M Rätsch; E Fabiani; M Rossini; F Bordicchia; F Candela; G V Coppa; P L Giorgi Journal: Lancet Date: 1994-01-22 Impact factor: 79.321
Authors: K F Freund; K P Doshi; S L Gaul; D A Claremon; D C Remy; J J Baldwin; S M Pitzenberger; A M Stern Journal: Biochemistry Date: 1994-08-23 Impact factor: 3.162
Authors: Jonas F Ludvigsson; Tim Card; Paul J Ciclitira; Gillian L Swift; Ikram Nasr; David S Sanders; Carolina Ciacci Journal: United European Gastroenterol J Date: 2015-04 Impact factor: 4.623
Authors: Maria Ines Pinto-Sanchez; Elena F Verdu; Maria C Gordillo; Julio C Bai; Stephen Birch; Paul Moayyedi; Premysl Bercik Journal: Can J Gastroenterol Hepatol Date: 2015-03
Authors: Olga Pulido; Marion Zarkadas; Sheila Dubois; Krista Macisaac; Isabelle Cantin; Sebastien La Vieille; Samuel Godefroy; Mohsin Rashid Journal: Can J Gastroenterol Date: 2013-08 Impact factor: 3.522